NeuralStem competitors

NeuralStem Competitors include InVivo Therapeutics, Pandion Therapeutics, ImCheck Therapeutics and Atara Biotherapeutics.
Add company...
NeuralStem
NeuralStem
NeuralStem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system.
InVivo Therapeutics
InVivo Therapeutics
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.
Pandion Therapeutics
Pandion Therapeutics
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.
ImCheck Therapeutics
ImCheck Therapeutics
ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .
Atara Biotherapeutics
Atara Biotherapeutics
Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.
Founding Date
Founding Date
1996
Founding Date
2005
Founding Date
2017
Founding Date
2015
Founding Date
2012
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Rockville, US HQ
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Locations
Marseille, FR HQ
Locations
South San Francisco, US HQ
Aurora, US
New York, US
Employees
Employees
11
Employees
37
Employees
176% increase
Employees
15
Employees
96
Valuation ($)
Valuation ($)
7.9 m
Valuation ($)
17.6 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.9 b
Twitter followers
Twitter followers
2.2 k
Twitter followers
1.2 k
Twitter followers
40
Twitter followers
N/A
Twitter followers
236

Financial

Net income
Net income
($15.7m) (FY, 2017)
Net income
($26.7m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
($119.5m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 58m (11 months ago)
Latest funding round
$ 1.1m (about 1 year ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 75.2m
Total funding raised
$ 58m
Total funding raised
$ 22.9m
Total funding raised
$ 61.8m
For sources of this data, please see the company profileDownload Excel

View company profiles

InVivo Therapeutics
HQ
Cambridge, US
Employees
37

InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.

View company
Pandion Therapeutics
HQ
Cambridge, US
Employees
17↑ 6% increase

Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.

View company
ImCheck Therapeutics
HQ
Marseille, FR
Employees
15

ImCheck Therapeutics is a biotech company developing the next generation of immune checkpoint modulators .

View company
Atara Biotherapeutics
HQ
South San Francisco, US
Employees
96

Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.

View company